NWPHF fundamentals
An in-depth look to NEWRON PHARMACEUTICALS S.P.A. operating, investing, and financing activities
NWPHF free cash flow for H2 23 is -4.98 M USD. For 2023, NWPHF free cash flow was -11.71 M USD and operating cash flow was -11.7 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM